The role of heparin in alleviating complement-mediated acute intravascular haemolysis

Acta Haematologica

Volumn 119, Issue 3, 2008, Pages 166-168

  Mannari, Deepak ^a,b   Liu, Christine ^a   Hughes, Derralynn ^a   Mehta, Atul ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autoimmune haemolytic anaemia; Complement; Haemolysis; Heparin; Paroxysmal nocturnal haemoglobinuria

Indexed keywords

AZATHIOPRINE; ENOXAPARIN; HEPARIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; WARFARIN;

ACUTE DISEASE; ADD ON THERAPY; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; CASE REPORT; DETERIORATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; FEMALE; FEVER; GENE MUTATION; HEMOGLOBINURIA; HEMOLYTIC ANEMIA; HUMAN; INTRAVASCULAR HEMOLYSIS; LABORATORY TEST; LOW DRUG DOSE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; TREATMENT RESPONSE;

3' UNTRANSLATED REGIONS; ACUTE DISEASE; ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; AZATHIOPRINE; COMBINED MODALITY THERAPY; COMPLEMENT ACTIVATION; ENOXAPARIN; FEMALE; HEMOLYSIS; HEPARIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; PLASMA EXCHANGE; PREDNISOLONE; PROTHROMBIN; SPLENECTOMY; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 46049089826     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000134221     Document Type: Article

References (7)

1. Tyrell DJ, Kilfeather S, Page CP: Therapeutic uses of heparin beyond its traditional role as an anticoagulant. Trends Pharmacol Sci 1995;16:198-204.
2. Logue GL: Effect of heparin on complement activation and lysis of paroxysmal nocturnal hemoglobinuria (PNH) red cells. Blood 1977;50:239-247.
3. Ninomiya H, Kawashima Y, Nagasawa T: Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin. Br J Haematol 2000;109:875-881.
4. Ninomiya H, Kawashima Y, Hasegawa Y, Nagasawa T: Complement-induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): implication for thrombogenesis in PNH. Br J Haematol 1999;106:224-231.
5. Ludwig RJ, Alban S, Boehncke WH: Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities. Mini Rev Med Chem 2006;6:1009-1023.
6. McFarland W, Galbraith RG, Miale A Jr: Heparin therapy in autoimmune hemolytic anemia. Blood 1960;15:741-747.
7. Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, Roth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L: The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006;355:1233-1243.